"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome Management.
Shickh S, Oldfield LE, Clausen M, Mighton C, Sebastian A, Calvo A, Baxter NN, Dawson L, Penney LS, Foulkes W, Basik M, Sun S, Schrader KA, Regier DA, Karsan A, Pollett A, Pugh TJ, Kim RH, Bombard Y; CHARM Consortium.
Shickh S, et al. Among authors: basik m.
Oncologist. 2022 May 6;27(5):e393-e401. doi: 10.1093/oncolo/oyac039.
Oncologist. 2022.
PMID: 35385106
Free PMC article.